Literature DB >> 31150980

Longitudinal analysis reveals early-pregnancy associations between perfluoroalkyl sulfonates and thyroid hormone status in a Canadian prospective birth cohort.

Anthony J F Reardon1, Elham Khodayari Moez2, Irina Dinu2, Susan Goruk3, Catherine J Field3, David W Kinniburgh4, Amy M MacDonald4, Jonathan W Martin5.   

Abstract

Serum perfluoroalkyl acids (PFAAs) have been linked to disruption of maternal thyroid hormone homeostasis, but results have varied between studies which we hypothesized was due to timing of the thyroid hormone measurements, variability in PFAA isomer patterns, or presence of other stressors. In a longitudinal study design, we investigated the time-dependency of associations between PFAA isomers and thyroid hormones during pregnancy and post-partum while considering thyroid peroxidase antibody (TPOAb) status and mercury (Hg) co-exposure. In participants of a prospective Canadian birth cohort (n = 494), free thyroxine (FT4), free triiodothyronine (FT3), thyroid stimulating hormone (TSH) and TPOAb were quantified in maternal plasma collected in each trimester and 3-months postpartum, and 25 PFAAs (15 linear and 10 branched) and Hg were quantified in samples collected during the second trimester. Perfluorohexane sulfonate (PFHxS) and total branched isomers of perfluorooctane sulfonate (PFOS) were positively associated with TSH in mixed-effect models, with strongest associations early in gestation. Throughout pregnancy and post-partum, PFHxS was inversely associated with FT4, consistent with elevated TSH, while Hg was inversely associated with FT3. In TPOAb-positive women, negative associations were found between PFUnA and FT4, and 1m-PFOS and TSH, supporting previous studies that thyroid disorder could increase susceptibility to PFAA-mediated hormone dysregulation. Hg did not confound associations but was a significant interaction term, revealing further positive associations between PFOS isomers (∑3m+4m-PFOS) and TSH. Higher perfluoroalkyl sulfonate exposures were associated with higher TSH and/or lower FT4, strongly suggestive that PFHxS and branched PFOS isomers are risk factors for subclinical maternal hypothyroidism. Isomer-specific analysis is important in future studies, as crude measures of 'total-PFOS' masked the associations of branched isomers. A concerning result was for PFHxS which had consistent negative associations with FT4 at all time points and a positive association with TSH in early pregnancy when fetal development is most sensitive to disruption.
Copyright © 2019 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Longitudinal study design; Perfluoroalkyl acids; Perfluoroalkyl carboxylates; Perfluoroalkyl sulfonates; Pregnancy; Thyroid hormones

Mesh:

Substances:

Year:  2019        PMID: 31150980      PMCID: PMC6859374          DOI: 10.1016/j.envint.2019.04.023

Source DB:  PubMed          Journal:  Environ Int        ISSN: 0160-4120            Impact factor:   9.621


  97 in total

1.  Perfluorohexane Sulfonate (PFHxS) and a Mixture of Endocrine Disrupters Reduce Thyroxine Levels and Cause Antiandrogenic Effects in Rats.

Authors:  Louise Ramhøj; Ulla Hass; Julie Boberg; Martin Scholze; Sofie Christiansen; Flemming Nielsen; Marta Axelstad
Journal:  Toxicol Sci       Date:  2018-06-01       Impact factor: 4.849

Review 2.  Thyroid hormone testing by tandem mass spectrometry.

Authors:  Offie P Soldin; Steven J Soldin
Journal:  Clin Biochem       Date:  2010-08-04       Impact factor: 3.281

3.  Effects of perfluorooctane sulfonate on rat thyroid hormone biosynthesis and metabolism.

Authors:  Wen-Guang Yu; Wei Liu; Yi-He Jin
Journal:  Environ Toxicol Chem       Date:  2009-05       Impact factor: 3.742

4.  Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. I: maternal and prenatal evaluations.

Authors:  Julie R Thibodeaux; Roger G Hanson; John M Rogers; Brian E Grey; Brenda D Barbee; Judy H Richards; John L Butenhoff; Lisa A Stevenson; Christopher Lau
Journal:  Toxicol Sci       Date:  2003-05-28       Impact factor: 4.849

5.  Perinatal outcome in hypothyroid pregnancies.

Authors:  A S Leung; L K Millar; P P Koonings; M Montoro; J H Mestman
Journal:  Obstet Gynecol       Date:  1993-03       Impact factor: 7.661

6.  Evaluation of potential reproductive and developmental toxicity of potassium perfluorohexanesulfonate in Sprague Dawley rats.

Authors:  John L Butenhoff; Shu-Ching Chang; David J Ehresman; Raymond G York
Journal:  Reprod Toxicol       Date:  2009-01-21       Impact factor: 3.143

7.  Perfluorinated compounds in delivering women from south central Vietnam.

Authors:  Charlotta Rylander; Duong Trong Phi; Jon Øyvind Odland; Torkjel M Sandanger
Journal:  J Environ Monit       Date:  2009-09-28

8.  Maternal and fetal exposure to cadmium, lead, manganese and mercury: The MIREC study.

Authors:  Tye E Arbuckle; Chun Lei Liang; Anne-Sophie Morisset; Mandy Fisher; Hope Weiler; Ciprian Mihai Cirtiu; Melissa Legrand; Karelyn Davis; Adrienne S Ettinger; William D Fraser
Journal:  Chemosphere       Date:  2016-08-16       Impact factor: 7.086

9.  Maternal thyroid peroxidase antibodies during pregnancy: a marker of impaired child development?

Authors:  V J Pop; E de Vries; A L van Baar; J J Waelkens; H A de Rooy; M Horsten; M M Donkers; I H Komproe; M M van Son; H L Vader
Journal:  J Clin Endocrinol Metab       Date:  1995-12       Impact factor: 5.958

10.  Prenatal exposure to endocrine disrupting chemicals in relation to thyroid hormone levels in infants - a Dutch prospective cohort study.

Authors:  Marijke de Cock; Michiel R de Boer; Marja Lamoree; Juliette Legler; Margot van de Bor
Journal:  Environ Health       Date:  2014-12-10       Impact factor: 5.984

View more
  6 in total

Review 1.  Exposure to Perflouroalkyl acids and foetal and maternal thyroid status: a review.

Authors:  Sophie A H Boesen; Manhai Long; Maria Wielsøe; Vicente Mustieles; Mariana F Fernandez; Eva C Bonefeld-Jørgensen
Journal:  Environ Health       Date:  2020-10-13       Impact factor: 5.984

2.  Maternal serum perfluoroalkyl substance mixtures and thyroid hormone concentrations in maternal and cord sera: The HOME Study.

Authors:  Rebecca M Lebeaux; Brett T Doherty; Lisa G Gallagher; R Thomas Zoeller; Andrew N Hoofnagle; Antonia M Calafat; Margaret R Karagas; Kimberly Yolton; Aimin Chen; Bruce P Lanphear; Joseph M Braun; Megan E Romano
Journal:  Environ Res       Date:  2020-03-16       Impact factor: 6.498

Review 3.  Legacy and Emerging Per- and Polyfluoroalkyl Substances: Analytical Techniques, Environmental Fate, and Health Effects.

Authors:  Richard A Brase; Elizabeth J Mullin; David C Spink
Journal:  Int J Mol Sci       Date:  2021-01-20       Impact factor: 5.923

Review 4.  Thyroid Disrupting Effects of Old and New Generation PFAS.

Authors:  Francesca Coperchini; Laura Croce; Gianluca Ricci; Flavia Magri; Mario Rotondi; Marcello Imbriani; Luca Chiovato
Journal:  Front Endocrinol (Lausanne)       Date:  2021-01-19       Impact factor: 5.555

Review 5.  Endocrine Disruptor Potential of Short- and Long-Chain Perfluoroalkyl Substances (PFASs)-A Synthesis of Current Knowledge with Proposal of Molecular Mechanism.

Authors:  Katarzyna Mokra
Journal:  Int J Mol Sci       Date:  2021-02-21       Impact factor: 5.923

Review 6.  A pathway level analysis of PFAS exposure and risk of gestational diabetes mellitus.

Authors:  Rahel L Birru; Hai-Wei Liang; Fouzia Farooq; Megha Bedi; Maisa Feghali; Catherine L Haggerty; Dara D Mendez; Janet M Catov; Carla A Ng; Jennifer J Adibi
Journal:  Environ Health       Date:  2021-05-22       Impact factor: 7.123

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.